No longer traded since 1996, when American Home products purchased the remaining 60% of the firms stock. Genetics Institute, Inc., a wholly-owned subsidiary of American Home Products Corporation, is a leading biopharmaceutical company engaged in the discovery, development and commercialization of human pharmaceuticals through recombinant DNA and other technologies. The company has a diversified portfolio of commercial, licensed, and proprietary pharmaceutical products at various stages of development, including treatments for anemia, hemophilia, cancer, bone damage, inflammatory conditions and immune system disorders. American Home Products is one of the world's largest research-based pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of prescription drugs and over-the-counter medicines. It is a global leader in vaccines, biotechnology, agricultural products and animal health care. Founded in 1980, Genetics Institute secured funding through venture capital, private placements and early licensing arrangements, which allowed the Company to build an effective infrastructure while developing a large portfolio of biopharmaceutical product candidates. Genetics Institute has R&D and production facilities in Cambridge and Andover, Massachusetts and offices in Paris, France and Tokyo, Japan
